FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to endocrinology, and can be used for treating type 2 diabetes mellitus. Oral antihyperglycemic preparations are used. Additionally, 0.1% dalargin solution is administered in dose of 1.0 ml intramuscularly 2 times day for 20 days. Further, to consolidate the obtained therapeutic effect, repeated similar courses of dalargin 0.1% solution in dose of 1.0 ml intramuscularly 2 times day for 20 days in 3, 6 and 9 months after the beginning of treatment.
EFFECT: invention provides a highly effective method for the integrated treatment of diabetes mellitus.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DIABETES MELLITUS | 2024 |
|
RU2834550C1 |
| METHOD OF TREATING CHRONIC KIDNEY DISEASE WITH DALARGIN | 2023 |
|
RU2819638C1 |
| METHOD OF TREATING HYPOTHYROIDISM WITH DALARGIN | 2023 |
|
RU2814749C1 |
| METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
| AGENT FOR TREATING TROPHIC ULCERS ACCOMPANYING DIABETIC FOOT SYNDROME | 2024 |
|
RU2831547C1 |
| METHOD OF TREATING CLIMACTERIC SYNDROME IN WOMEN | 2024 |
|
RU2821826C1 |
| EXENATIDE AND DALARGIN DRUG FOR TREATING DIABETES, ADMINISRATION AND THERAPY | 2007 |
|
RU2413528C2 |
| METHOD OF TREATING OSTEOARTHRITIS WITH COMBINATION OF DALARGIN AND POLYACLYLAMIDE | 2024 |
|
RU2828962C1 |
| GEL FOR TREATING DIABETIC POLYNEUROPATHY OF LOWER EXTREMITIES | 2024 |
|
RU2829250C1 |
| METHOD OF TREATING KNEE OSTEOARTHRITIS | 2024 |
|
RU2822321C1 |
